Our Pricing

Omeprazole Side Effects vs Gaviscon: Treatment Guide

Published on: June 03, 2026

Comparing omeprazole side effects vs Gaviscon is essential when choosing the right acid reflux treatment for your needs. At Cured Pharmacy, our UK-registered clinical team helps patients understand the key differences between proton pump inhibitors like omeprazole and antacids like Gaviscon, ensuring you receive the most appropriate treatment after a free online consultation.

How Omeprazole and Gaviscon Work Differently

Omeprazole belongs to a class of medicines called proton pump inhibitors (PPIs), which work by blocking the proton pumps in your stomach lining that produce acid [1]. This mechanism reduces acid production by up to 90% within 24 hours, providing long-lasting relief for conditions like gastro-oesophageal reflux disease (GORD) and peptic ulcers [1][2].

Gaviscon, by contrast, is an alginate-based antacid that works immediately upon contact with stomach acid to form a protective raft barrier [3]. This physical barrier floats on top of stomach contents, preventing acid from refluxing into the oesophagus whilst neutralising existing acid. The effect is rapid but typically lasts only 3-4 hours, making it suitable for occasional heartburn rather than chronic conditions [3].

The fundamental difference lies in prevention versus symptom relief: omeprazole prevents acid production at the cellular level, whilst Gaviscon manages acid that has already been produced. This distinction determines which treatment is most appropriate for your specific symptoms and frequency of acid reflux episodes.

Common Omeprazole Side Effects UK Patients Experience

The most frequently reported omeprazole side effects in UK clinical practice include headache (affecting up to 7% of patients), gastrointestinal disturbances such as diarrhoea, constipation, or abdominal pain (occurring in approximately 5-8% of users), and nausea [1][4]. These effects are generally mild and often resolve within the first few weeks of treatment as your body adjusts to the medication.

Long-term use of omeprazole, particularly at higher doses or for periods exceeding one year, may be associated with reduced magnesium levels, increased risk of bone fractures, and potential vitamin B12 deficiency [4][5]. UK prescribers typically monitor patients on extended PPI therapy and may recommend periodic blood tests to assess mineral and vitamin levels, particularly in elderly patients or those with additional risk factors.

Serious side effects are rare but include severe allergic reactions, liver problems, and a small increased risk of Clostridium difficile infection [4]. If you experience severe diarrhoea, unexplained weight loss, persistent vomiting, or signs of liver dysfunction such as yellowing of the skin or eyes, you should contact your GP or prescriber immediately.

When to Seek Medical Advice

Whilst omeprazole is generally well-tolerated, certain symptoms warrant immediate medical attention. Severe stomach pain, blood in vomit or stools, difficulty swallowing, or unexplained weight loss may indicate serious underlying conditions that require urgent assessment. Your UK prescriber will evaluate these symptoms during your clinical consultation to determine the most appropriate treatment pathway.

Gaviscon Side Effects and Safety Profile

Gaviscon has a notably favourable safety profile compared to systemic medications, as it works locally in the stomach without significant absorption into the bloodstream [3]. The most common side effects are mild and include constipation or diarrhoea, depending on the formulation, and occasional bloating due to the alginate's gas-forming properties [3].

Because Gaviscon contains sodium and calcium salts, patients with heart failure, kidney disease, or those on sodium-restricted diets should consult a healthcare professional before regular use [3]. Gaviscon Advance, which contains potassium rather than sodium, may be more suitable for these patients, though potassium levels should be monitored in individuals with renal impairment.

Allergic reactions to Gaviscon are extremely rare but may occur in patients sensitive to alginates or other ingredients. The medication is generally considered safe for short-term use during pregnancy and breastfeeding, making it a preferred first-line option for acid reflux in pregnant women, though medical advice should always be sought [3].

Omeprazole vs Gaviscon: Effectiveness for Different Conditions

Clinical evidence demonstrates that omeprazole and other PPIs are superior to antacids for treating erosive oesophagitis and GORD, with healing rates of approximately 80-90% after 8 weeks of treatment [1][2]. For patients experiencing frequent heartburn (more than twice weekly) or diagnosed with GORD, omeprazole provides more comprehensive symptom control and allows oesophageal healing that Gaviscon cannot achieve.

Gaviscon excels in managing occasional heartburn, postprandial reflux, and symptoms triggered by specific foods or situations [3]. Its rapid onset of action—typically within 3-5 minutes—makes it ideal for immediate symptom relief, whilst omeprazole requires 1-4 days to reach maximum effectiveness [1][3]. Many UK patients find that Gaviscon works well for lifestyle-related reflux, such as symptoms after large meals or when lying down.

For nocturnal reflux symptoms, the combination approach is sometimes recommended: omeprazole taken once daily to suppress acid production, with Gaviscon used as needed for breakthrough symptoms [2]. This strategy, subject to prescriber approval, addresses both the underlying acid production and provides immediate relief when required.

Treatment Selection Based on Symptom Frequency

UK clinical guidelines suggest that symptom frequency should guide initial treatment choice. Occasional heartburn occurring less than twice weekly typically responds well to antacids like Gaviscon, whilst frequent symptoms or those interfering with daily activities warrant PPI therapy such as omeprazole. Your UK prescriber will assess your symptom pattern, medical history, and any red flag symptoms during your online consultation to recommend the most appropriate treatment pathway.

Cost Comparison and Value for Money

Omeprazole represents excellent value for UK patients requiring daily acid suppression, with generic formulations available from £9.99 for a 28-day supply at Cured Pharmacy. This equates to approximately 21 pence per day for effective GORD management, significantly lower than typical high-street pricing.

Gaviscon, whilst available over the counter without prescription, can become costly with regular use. A 500ml bottle providing approximately 50 doses typically costs between £9.99-8, meaning daily use costs 12-16 pence per dose but requires multiple doses throughout the day. For chronic symptoms requiring 3-4 doses daily, monthly costs can exceed the price of prescription PPI therapy.

Alternative PPIs available at Cured Pharmacy include lansoprazole, pantoprazole, and esomeprazole, all offering similar efficacy with slight variations in dosing schedules and individual response. Our UK prescribers will recommend the most cost-effective option based on your specific clinical needs, with transparent pricing displayed before your consultation.

Which Treatment Is Right for You?

Choosing between omeprazole side effects vs Gaviscon depends on your symptom severity, frequency, and underlying diagnosis. Patients with infrequent heartburn, pregnancy-related reflux, or those preferring non-prescription options often find Gaviscon sufficient for symptom management [3]. The minimal systemic absorption and rapid action make it ideal for situational use and immediate relief.

Omeprazole is typically recommended for patients with diagnosed GORD, erosive oesophagitis, frequent heartburn (more than twice weekly), or those who have not achieved adequate relief with antacids [1][2]. The once-daily dosing and superior healing rates make it the preferred choice for chronic acid-related conditions, though it requires prescription and clinical assessment by a UK prescriber.

At Cured Pharmacy, our online consultation process takes under 3 minutes and allows our UK-registered prescribers to assess your symptoms, medical history, and current medications to determine the most appropriate treatment. All prescription medications, including omeprazole, lansoprazole, and other PPIs, require this clinical assessment to ensure safe and effective treatment tailored to your individual needs.

Starting Your Treatment Journey

Beginning treatment for acid reflux at Cured Pharmacy is straightforward and completely confidential. Complete our free online consultation, receive a clinical assessment from a UK prescriber, and if approved, your medication will be dispensed by our UK-registered pharmacy team and delivered in discreet packaging. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services to ensure the highest standards of patient care and medication safety.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
3. Mandel, K. G., Daggy, B. P., Brodie, D. A., & Jacoby, H. I. (2000). Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Alimentary Pharmacology & Therapeutics, 14(6), 669–690. https://doi.org/10.1046/j.1365-2036.2000.00759.x [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors in long-term use: reports of hypomagnesaemia. Drug Safety Update, 5(11), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia [accessed 13 August 2026]
5. Freedberg, D. E., Kim, L. S., & Yang, Y. X. (2017). The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology, 152(4), 706–715. https://doi.org/10.1053/j.gastro.2017.01.031 [accessed 13 August 2026]
6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.